Tumor cells often upregulate ST6GAL1, leading to increased α2-6-sialylation of the Fas receptor (FasR) and tumor necrosis factor receptor 1, which suppresses cancer apoptosis and facilitates the formation of secondary tumor sites [90]. The gene discussed is ST6GAL1; the disease is neoplasm.